18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma
NCT04001257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-01-18
Summary
Role of 18F-FET PET for grading gliomas according to 2016 WHO classification: value of quantitative and qualitative data obtained by 18F-FET PET for differentiating low grade glioma (WHO II) versus high grade gliomas (WHO III and IV)
Conditions
- Positron Emission Tomography
- Glioma
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Principal Investigators
-
solene querellou, MD · CHRU Brest
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-17
- Primary Completion
- 2019-09-17
- Completion
- 2019-09-17
Countries
- France
Study Locations
More Related Trials
-
18F-FET PET/CT in the Management of Glioma
NCT06563024 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics
NCT05512403 ·Status: RECRUITING ·Phase: PHASE3
-
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
NCT04464590 ·Status: COMPLETED
-
Molecular Pituitary Imaging Using 18F-FET PET
NCT06584123 ·Status: RECRUITING ·Phase: NA
-
POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
NCT02631655 ·Status: COMPLETED ·Phase: NA
-
Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors
NCT03525080 ·Status: COMPLETED ·Phase: NA
-
PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma
NCT02601547 ·Status: COMPLETED ·Phase: NA
-
Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years
NCT03582254 ·Status: UNKNOWN ·Phase: NA
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]-FMISO for Non Operated Glioblastoma
NCT00906893 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FET PET in Childhood Brain Tumours
NCT03216148 ·Status: UNKNOWN ·Phase: PHASE2
-
FET-PET Directed Simultaneous In-field Boost for Primary GBM
NCT04790097 ·Status: COMPLETED ·Phase: NA
-
Radionecrosis and FDG PET
NCT02391246 ·Status: UNKNOWN
-
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
NCT00624728 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
NCT01540513 ·Status: COMPLETED ·Phase: NA
-
Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology
NCT06612567 ·Status: NOT_YET_RECRUITING
-
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
NCT01842217 ·Status: TERMINATED ·Phase: NA
-
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations
NCT02858167 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)
NCT02352064 ·Status: UNKNOWN ·Phase: NA
-
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
NCT04008095 ·Status: COMPLETED
-
The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents
NCT03402425 ·Status: UNKNOWN ·Phase: NA
-
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
NCT04315584 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma
NCT00915096 ·Status: COMPLETED
-
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
NCT00943462 ·Status: WITHDRAWN